The promotion of bone regeneration through positive regulation of angiogenic–osteogenic coupling using microRNA-26a

Crane, 1995, Bone tissue engineering, Nat Med, 1, 1322, 10.1038/nm1295-1322 Rouwkema, 2008, Vascularization in tissue engineering, Trends Biotechnol, 26, 434, 10.1016/j.tibtech.2008.04.009 Gerber, 2000, Angiogenesis and bone growth, Trends Cardiovasc Med, 10, 223, 10.1016/S1050-1738(00)00074-8 Collin-Osdoby, 1994, Role of vascular endothelial cells in bone biology, J Cell Biochem, 55, 304, 10.1002/jcb.240550306 Baron, 1994, Induction of growth plate cartilage ossification by basic fibroblast growth factor, Endocrinology, 135, 2790, 10.1210/endo.135.6.7988472 Ivkovic, 2003, Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development, Development, 130, 2779, 10.1242/dev.00505 Kanczler, 2008, Osteogenesis and angiogenesis: the potential for engineering bone, Eur Cell Mater, 15, 100, 10.22203/eCM.v015a08 Schipani, 2009, Regulation of osteogenesis–angiogenesis coupling by HIFs and VEGF, J Bone Miner Res, 24, 1347, 10.1359/jbmr.090602 Lin, 2011, Synergistic inhibition of endochondral bone formation by silencing Hif1alpha and Runx2 in trauma-induced heterotopic ossification, Mol Ther, 19, 1426, 10.1038/mt.2011.101 Peng, 2002, Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4, J Clin Invest, 110, 751, 10.1172/JCI15153 Wadhwa, 2007, Impaired posterior frontal sutural fusion in the biglycan/decorin double deficient mice, Bone, 40, 861, 10.1016/j.bone.2006.11.003 Wildemann, 2004, Local and controlled release of growth factors (combination of IGF-I and TGF-beta I, and BMP-2 alone) from a polylactide coating of titanium implants does not lead to ectopic bone formation in sheep muscle, J Control Release, 95, 249, 10.1016/j.jconrel.2003.11.014 Zhang, 2009, The synergetic bone-forming effects of combinations of growth factors expressed by adenovirus vectors on chitosan/collagen scaffolds, J Control Release, 136, 172, 10.1016/j.jconrel.2009.02.016 Cook, 1994, Recombinant human bone morphogenetic protein-7 induces healing in a canine long-bone segmental defect model, Clin Orthop Relat Res, 302 Cook, 1995, Effect of recombinant human osteogenic protein-1 on healing of segmental defects in non-human primates, J Bone Joint Surg Am, 77, 734, 10.2106/00004623-199505000-00010 Andreadis, 2006, Biomimetic approaches to protein and gene delivery for tissue regeneration, Trends Biotechnol, 24, 331, 10.1016/j.tibtech.2006.05.001 Chen, 2010, Toward delivery of multiple growth factors in tissue engineering, Biomaterials, 31, 6279, 10.1016/j.biomaterials.2010.04.053 Yau, 2012, Directing stem cell fate by controlled RNA interference, Biomaterials, 33, 2608, 10.1016/j.biomaterials.2011.12.021 Bartel, 2004, MicroRNAs: genomics, biogenesis, mechanism, and function, Cell, 116, 281, 10.1016/S0092-8674(04)00045-5 Krek, 2005, Combinatorial microRNA target predictions, Nat Genet, 37, 495, 10.1038/ng1536 Li, 2009, A novel microRNA targeting HDAC5 regulates osteoblast differentiation in mice and contributes to primary osteoporosis in humans, J Clin Invest, 119, 3666, 10.1172/JCI39832 Zhang, 2011, MiRNA-20a promotes osteogenic differentiation of human mesenchymal stem cells by co-regulating BMP signaling, RNA Biol, 8, 829, 10.4161/rna.8.5.16043 Yang, 2012, TNF-alpha suppresses the mesenchymal stem cell osteogenesis promoter miR-21 in estrogen deficiency-induced osteoporosis, J Bone Miner Res Li, 2009, Biological functions of miR-29b contribute to positive regulation of osteoblast differentiation, J Biol Chem, 284, 15676, 10.1074/jbc.M809787200 Eskildsen, 2011, MicroRNA-138 regulates osteogenic differentiation of human stromal (mesenchymal) stem cells in vivo, Proc Natl Acad Sci U S A, 108, 6139, 10.1073/pnas.1016758108 Luzi, 2008, Osteogenic differentiation of human adipose tissue-derived stem cells is modulated by the miR-26a targeting of the SMAD1 transcription factor, J Bone Miner Res, 23, 287, 10.1359/jbmr.071011 Huse, 2009, The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo, Genes Dev, 23, 1327, 10.1101/gad.1777409 Su, 2003, PTEN and phosphatidylinositol 3′-kinase inhibitors up-regulate p53 and block tumor-induced angiogenesis: evidence for an effect on the tumor and endothelial compartment, Cancer Res, 63, 3585 Ma, 2010, miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis, Nat Cell Biol, 12, 247, 10.1038/ncb2024 Liu, 2011, MiR-21 induced angiogenesis through AKT and ERK activation and HIF-1alpha expression, PLoS One, 6, e19139, 10.1371/journal.pone.0019139 Krutzfeldt, 2005, Silencing of microRNAs in vivo with ‘antagomirs’, Nature, 438, 685, 10.1038/nature04303 Matsubara, 2005, Alveolar bone marrow as a cell source for regenerative medicine: differences between alveolar and iliac bone marrow stromal cells, J Bone Miner Res, 20, 399, 10.1359/JBMR.041117 Zhou, 2010, The repair of large segmental bone defects in the rabbit with vascularized tissue engineered bone, Biomaterials, 31, 1171, 10.1016/j.biomaterials.2009.10.043 Boerckel, 2011, Mechanical regulation of vascular growth and tissue regeneration in vivo, Proc Natl Acad Sci U S A, 108, E674, 10.1073/pnas.1107019108 Yoshikawa, 2001, Fatal acute myocarditis in an infant with human herpesvirus 6 infection, J Clin Pathol, 54, 792, 10.1136/jcp.54.10.792 Oskowitz, 2008, Human multipotent stromal cells from bone marrow and microRNA: regulation of differentiation and leukemia inhibitory factor expression, Proc Natl Acad Sci U S A, 105, 18372, 10.1073/pnas.0809807105 Zhang, 2000, VEGF enhances angiogenesis and promotes blood–brain barrier leakage in the ischemic brain, J Clin Invest, 106, 829, 10.1172/JCI9369 Tille, 2001, Vascular endothelial growth factor (VEGF) receptor-2 antagonists inhibit VEGF- and basic fibroblast growth factor-induced angiogenesis in vivo and in vitro, J Pharmacol Exp Ther, 299, 1073 Armulik, 2005, Endothelial/pericyte interactions, Circ Res, 97, 512, 10.1161/01.RES.0000182903.16652.d7 Lian, 2012, MicroRNA control of bone formation and homeostasis, Nat Rev Endocrinol, 8, 212, 10.1038/nrendo.2011.234 Wienholds, 2005, MicroRNA function in animal development, FEBS Lett, 579, 5911, 10.1016/j.febslet.2005.07.070 Manaka, 2011, Local delivery of siRNA using a biodegradable polymer application to enhance BMP-induced bone formation, Biomaterials, 32, 9642, 10.1016/j.biomaterials.2011.08.026 Mariner, 2012, Manipulation of miRNA activity accelerates osteogenic differentiation of hMSCs in engineered 3D scaffolds, J Tissue Eng Regen Med, 6, 314, 10.1002/term.435 Lian, 2006, Networks and hubs for the transcriptional control of osteoblastogenesis, Rev Endocr Metab Disord, 7, 1, 10.1007/s11154-006-9001-5 Cowles, 1998, Mineralization and the expression of matrix proteins during in vivo bone development, Calcif Tissue Int, 62, 74, 10.1007/s002239900397 Cai, 2005, Injectable glycosaminoglycan hydrogels for controlled release of human basic fibroblast growth factor, Biomaterials, 26, 6054, 10.1016/j.biomaterials.2005.03.012 Oh, 2009, siRNA delivery systems for cancer treatment, Adv Drug Deliv Rev, 61, 850, 10.1016/j.addr.2009.04.018 Schumann, 2009, Consequences of seeded cell type on vascularization of tissue engineering constructs in vivo, Microvasc Res, 78, 180, 10.1016/j.mvr.2009.06.003 Al-Khaldi, 2003, Postnatal bone marrow stromal cells elicit a potent VEGF-dependent neoangiogenic response in vivo, Gene Ther, 10, 621, 10.1038/sj.gt.3301934